Sequent Scientific Limited, a active public limited company, was established on 28 June 1985 in Shaikpet, Telangana, India. Engaging in pharmaceuticals within the manufacturing sector, it holds CIN: L99999MH1985PLC036685. Registered under ROC Roc Hyderabad. it is listed on BSE: 512529 and NSE: EQUENT. It has an authorized capital of ₹886.15 Cr and a paid-up capital of ₹50.82 Cr.
Formerly known as Visistha Trades & Finance Limited, P.I. Drugs & Pharmaceuticals Limited. It upholds a compliant status. In 2023, it reported revenue of ₹250.93 Cr and a net worth of ₹1,058.36 Cr. Employing 399 professional, Its leadership includes Gregory John Andrews (Director), Fabian Martin Kausche (Director), Revati Parag Kasture (Director). Past directors included Gautam Kumar Das, Joe Thomas Mangalam, Ramanujam Kannan. It holds ₹792.71 Cr open charges and ₹1,663.84 Cr settled loans. Its latest AGM occurred on 08 August 2025, with the balance sheet filed on 31 March 2025. It is based at 3Rd Floor, Srivalli S Corporate, Plot No. 290,, Syn 33 34P To 39, Guttala Begumpet, Shaikpet, Telangana, 500033.
L99999TS1985PLC196357
196357
28 June 1985
₹886.15 Cr
₹50.82 Cr
Roc Hyderabad
Listed (BSE: 512529, NSE: EQUENT)
Active
Explore comprehensive insights into Sequent Scientific Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gregory John Andrews | Director | 06 Nov 2020 | Current |
| Fabian Martin Kausche | Director | 14 Dec 2020 | Current |
| Revati Parag Kasture | Director | 17 Dec 2024 | Current |
| Milind Shripad Sarwate | Director | 25 Aug 2020 | Current |
| Kamal Kishore Sharma | Director | 25 Aug 2020 | Current |
| Anuj Vishnukumar Poddar | Director | 05 Sep 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Managing Director | 08 Jan 2017 | Past |
| Pramod Abcsdd | Director | 18 Jan 2012 | Past |
| Pramod Abcsdd | Director | 11 Feb 2016 | Past |
| Pramod Abcsdd | Additional Director | 23 Sep 2016 | Past |
| Pramod Abcsdd | Additional Director | 23 Sep 2016 | Past |
| Pramod Abcsdd | Additional Director | 17 Jan 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Sequent Scientific's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹7,927,084,880.00
₹16,638,400,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Oct 2025 | Hdfc Bank Limited | ₹3.89 M | Open |
| 04 Oct 2025 | Hdfc Bank Limited | ₹3.89 M | Open |
| 25 Sep 2025 | Hdfc Bank Limited | ₹1.75 M | Open |
| 24 Sep 2025 | Hdfc Bank Limited | ₹1.65 M | Open |
| 05 Mar 2025 | Hdfc Bank Limited | ₹2.46 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Sequent Scientific, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sequent Scientific, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sequent Scientific's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Hari Babu Bodepudi was appointed as a CEO was appointed as a CEO on 16 Dec 2025 & has been associated with this company since 1 month . was recorded as a recent event.
A charge with Hdfc Bank Limited amounted to Rs. 0.39 Cr with Charge ID 101188521 was registered on 27 Oct 2025. was recorded as a recent event.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.39 Cr with Charge ID 101169395 was registered on 04 Oct 2025. was documented.
A charge with Hdfc Bank Limited amounted to Rs. 0.18 Cr with Charge ID 101177637 was registered on 25 Sep 2025. was recorded as a recent event.
The activity A charge with Hdfc Bank Limited amounted to Rs. 0.17 Cr with Charge ID 101177005 was registered on 24 Sep 2025. was completed.
Anuj Vishnukumar Poddar was appointed as a Director was appointed as a Director on 05 Sep 2025 & has been associated with this company since 4 months 13 days . was recorded as a recent event.
The animal healthcare company also looks to tap into multibillion dollar foreign markets to expand its growth potential..
The CIN of Sequent Scientific Limited is L99999TS1985PLC196357.
Sequent Scientific Limited is headquartered at 3Rd Floor, Srivalli S Corporate, Plot No. 290,, Syn 33 34P To 39, Guttala Begumpet, Shaikpet, Telangana, 500033.
Sequent Scientific Limited was incorporated on 28 June 1985.
The current directors of Sequent Scientific Limited are
The primary industry of Sequent Scientific Limited is Manufacturing.
Sequent Scientific Limited is listed. It is listed on BSE: 512529 and NSE: EQUENT.
The authorized capital of Sequent Scientific Limited is ₹886.15 Cr, and the paid-up capital is ₹50.82 Cr.
The compliance status of Sequent Scientific Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX